Regulatory Roundup: Jose Delgado, Saffie Joseph Jr., Douglas Nunn, Mario Serey Jr. Sanctioned

Regulators in New Jersey and Maryland have issued a number of rulings in recent months for medication violations involving trainers Jose H. Delgado, Douglas Nunn, Saffie Joseph Jr., and Mario Serey Jr.

Two horses were disqualified from stakes wins for medication violations.

The Critical Way's victory in the June 19 Get Serious Stakes at Monmouth Park was taken away after the 7-year-old gelding tested positive for levamisole. Trainer Jose H. Delgado was given a 15-day suspension from Oct. 11-Oct. 25 and he was fined $500.

The Critical Way, who went on to win two subsequent stakes, including the Grade 3 Parx Dash on Aug. 31, is owned by Randal Gindi's Monster Racing Stables. Gindi in 2017 was fined $5,000 for “conduct detrimental to racing” in connection with a cell phone video in which he Jorge Navarro, his trainer at the time, could be heard joking about giving “juice” to horses and Gindi said he bet on them through a bookmaker Navarro recently pleaded guilty to federal charges of drug adulteration and misbranding.

Delgado was suspended an additional 15 days, from Sept. 26-Oct. 10 and fined $500 for a second incident in New Jersey when Glory Roll tested positive for an overage of phenylbutazone in a post-race sample from a June 13 race in which the mare finished fifth as the 3-2 favorite. Glory Roll is owned by Carole Star Stable.

Trainer Douglas Nunn was suspended 15 days from Oct. 16-30 and fined $500 after Team Effort tested positive for flunixin following a second-place finish in a May 31 Monmouth Park race.Team Effort, owned by Winner Circle Stables LLC, was disqualified from purse money in the race. The horse is entered to race Oct. 15 at Meadowlands with David Nunn as trainer.

Trainer Saffie Joseph Jr. was fined $1,000 and the horse Wind of Change was disqualified from his victory at Monmouth Park in the Mr. Prospector Stakes on May 29 after testing positive for aminocaproic acid (better known as Amicar), an adjunct bleeder medication. Wind of Change is owned by Daniel Alonso.

The sanctions against Delgado,  Joseph and Nunn were first reported by Bloodhorse.com.

Earlier this year, trainer Mario Serey Jr. was sanctioned in Maryland for two clenbuterol violations. Amen Corner, second in a May 20 race at Pimlico, was disqualified and placed last after testing positive for the bronchodilator. Family Fortune was disqualified from a May 21 win at Pimlico. Serey owns Amen Corner, while Family Fortune is owned by K12 LLC.

For both violations, Serey was fined $500. He received a 15-day suspension that was stayed, provided he does not pick up another Class 3 violation within a 365-day period. Serey served a 165-day suspension in 2019 after receiving a number of clenbuterol positives in Pennsylvania.

All of the positive tests were reported by Industrial Laboratories of Wheat Ridge, Colo. Industrial replaced Truesdail Laboratories of Irvine, Calif.,  as the official testing lab in a number of states over the past year, including New Jersey and Maryland.

The post Regulatory Roundup: Jose Delgado, Saffie Joseph Jr., Douglas Nunn, Mario Serey Jr. Sanctioned appeared first on Horse Racing News | Paulick Report.

Source of original post

West Virginia Officials Awaiting Split Sample Results On Georgina Baxter-Trained Charles Town Oaks Winner

Georgina Baxter, one of five Florida-based trainers sanctioned on Oct. 1 by Gulfstream Park for violating the track's house rules on clenbuterol, may be in jeopardy of losing her biggest career win after a horse in her care, R Adios Jersey, tested positive for the anti-inflammatory flunixin (trade name Banamine) following the $400,000, Grade 3 Charles Town Oaks in West Virginia on Aug. 27.

West Virginia Racing Commission steward Denver Beckner confirmed the initial finding from Industrial Laboratories in Colorado and said officials are awaiting results of a confirmatory split sample before conducting a hearing to consider possible disqualification of R Adios Jersey and sanctions that could include a fine and/or suspension of Baxter.

R Adios Jersey, a Florida-bred 3-year-old filly by Adios Charlie, is owned by Averill Racing LLC and ATM Racing. Her front-running, 3 1/4-length victory under Paco Lopez was her fourth victory without a defeat. R Adios Jersey earned $230,400 and paid a $12.80 mutuel for the Charles Town Oaks win.

Banamine is a Class 4 drug with a Category C penalty under Association of Racing Commissioners International guidelines. For flunixin, under those guidelines, if the sample tests higher than 5 ng/ml, the recommendation is for a disqualification and loss of purse in the absence of mitigating circumstances. A trainer faces a maximum fine of $1,000 for a first offense in any jurisdiction and a $1,500 fine and 15-day suspension for a second offense in a 365-day period in any jurisdiction, under the ARCI guidelines.

Baxter, a native of England who was a jockey and exercise rider, took over the stable of Ralph Ziadie in 2018 after the latter was denied a license renewal by the Florida Division of Pari-Mutuel Wagering because of multiple medication violations. Ralph's son, Kirk Ziadie, who won numerous South Florida training titles during his career, is serving a six-year license suspension for multiple clenbuterol violations that runs through Jan. 10, 2022.

According to the MyFloridaLicense.com website, Baxter has had six complaints filed against her for Class 4 medication violations since August 2018, most recently on Nov. 5, 2020. She served a 25-day suspension earlier last year for three violations that involved impermissible levels of flunixin and phenylbutazone.

According to Equibase, Baxter has won 132 of 502 starts (26%) and her horses have earned $3,999,741.

On Friday, Baxter was one of five trainers suspended by Gulfstream Park for violating the track's house rules concerning clenbuterol. The bronchodilator was detected in 12 horses from five of the 10 stables tested out-of-competition using hair and blood samples. The other trainers sanctioned were Rohan Crichton, Daniel Pita, Peter Walder, and Gilberto Zerpa.

The post West Virginia Officials Awaiting Split Sample Results On Georgina Baxter-Trained Charles Town Oaks Winner appeared first on Horse Racing News | Paulick Report.

Source of original post

Potts Suspended 15-Days For New Jersey Medication Violation

Wayne Potts, leading trainer at the 2021 Monmouth Park meet in Oceanport, N.J., received a 15-day suspension and $500 fine from the track's board of stewards for an overage of the non-steroidal anti-inflammatory flunixin (trade name Banamine).

Potts indicated to Daily Racing Form he will appeal the ruling – which set the suspension dates from Sept. 1-15, inclusive – adding that he would likely wind up serving the suspension at the beginning of the 2022 meet. Potts was also assigned a half point under the multiple medication violation (MMV) program.

Kentucky Cool won the second race at Monmouth for Potts and owner Bruno Schickedanz on June 5 and was subsequently found by Industrial Laboratories of Wheat Ridge, Colo., to have flunixin at 10.1 nanograms per milliliter in his blood sample, twice the amount permitted.

Potts told Daily Racing Form that Kentucky Cool may have inadvertently received two doses of flunixin – one at Belmont Park, where he was stabled, and another at Monmouth Park after arriving there two days before the race.

Potts, with 24 wins from 93 starts at Monmouth Park this year, was most recently sanctioned for a medication violation in 2019.

Kentucky Cool was disqualified from the June 5 race with the $13,200 purse money he earned redistributed. He was claimed from that race by owner-trainer Anthony Foglia and has subsequently finished fifth (of five runners), 10th (of 10), eighth (of 9) and third (of nine).

 

The post Potts Suspended 15-Days For New Jersey Medication Violation appeared first on Horse Racing News | Paulick Report.

Source of original post

Pain Management Strategies for Laminitic Horses: Different Solutions For Different Causes 

Very few equine conditions can be as debilitating as laminitis, which can be triggered by a variety of events or occur on its own. Laminitis occurs when the laminae, a set of finger-like structures which support the coffin bone and hold it in place in the hoof capsule, become inflamed. This inflammation is incredibly painful and can be catastrophic for the horse's athletic career.  

Many horses that develop laminitis are not euthanized because of the changes to the laminae, but because of the uncontrollable pain the condition brings on. A virtual session of the 2020 American Association of Equine Practitioners annual convention summarized the current research on the best way to manage pain in different types of laminitis cases.

The pain a laminitic horse feels is multidimensional. It can be brought on by pressure within the hoof capsule, inflammation of the laminae, tearing of soft tissues, a reduction of blood supply to the hoof, contact between the coffin bone and the sole of the hoof, and neuropathic pain.  

Dr. Katherine Ellis of Gail Holmes Equine Orthopaedic Research Center at Colorado State University, explained several different strategies for different causes of laminitis. Phenylbutazone (bute) is commonly given to treat laminitis, but that other drugs, including as flunixin, ketoprofen or firocoxib, may be better at controlling laminitic pain.

Ellis stressed that if an NSAID doesn't seem to be providing pain relief to a laminitic horse, another should be considered. A horse that has developed laminitis from overindulging in grain would benefit from having his hooves submerged ice water. This will be helpful for controlling pain and limiting injury. Ideally, the hooves would be submerged constantly for 48 to 72 hours, though this is a labor-intense endeavor. 

Metabolic issues like equine metabolic syndrome (EMS) and Cushing's disease can put a horse at risk for chronic laminitis. Gabapentin has been shown to be an effective pain medication for horses with chronic laminitis, but higher doses of pain medications may be necessary to provide relief. 

Ellis noted that acupuncture and use of a TENS unit may offer some additional pain relief. Chiropractic work and massage may offer respite from body pain brought on by the laminitic stance.

A horse that has an injury to a leg may develop supporting limb laminitis. Ellis suggests using morphine and butorphanol blocks and fentanyl patches to help control pain in these cases. A tramadol and ketamine infusion can also be used. Ellis notes that biologics like stem cells and platelet-rich plasma can be used for the anti-inflammatory properties. 

Read more at EquiManagement

The post Pain Management Strategies for Laminitic Horses: Different Solutions For Different Causes  appeared first on Horse Racing News | Paulick Report.

Source of original post

Verified by MonsterInsights